HIF-prolyl hydroxylase inhibitors for anemia treatment in chronic kidney disease patients. Manufactured and supplied to nephrology departments, dialysis centers, and hospital pharmacies for procurement by renal specialists managing hemoglobin levels in outpatient and inpatient renal care settings.